Lectin-mediated drug targeting: Preparation, binding characteristics, and antiproliferative activity of wheat germ agglutinin conjugated doxorubicin on Caco-2 cells

Pharmaceutical Research

Volumn 15, Issue 7, 1998, Pages 1031-1037

  Wirth, Michael ^a   Fuchs, Andrea ^a   Wolf, Michaela ^a   Ertl, Bernhard ^a   Gabor, Franz ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Caco 2; Doxorubicin; Drug targeting; Lectin; Wheat germ agglutinin

Indexed keywords

DOXORUBICIN; DOXORUBICIN DERIVATIVE; WHEAT GERM AGGLUTININ;

ARTICLE; CELL STRAIN CACO 2; COLON CARCINOMA; CONTROLLED STUDY; CYTOSTASIS; DRUG CONJUGATION; DRUG SYNTHESIS; DRUG TARGETING; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL;

ACONITIC ACID; ANTIBIOTICS, ANTINEOPLASTIC; CACO-2 CELLS; CELL DIVISION; CELLS, CULTURED; CHEMISTRY, PHARMACEUTICAL; COLON; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FLOW CYTOMETRY; HUMANS; LYMPHOCYTES; WHEAT GERM AGGLUTININS;

EID: 0031848767     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011926026653     Document Type: Article

References (22)

1. R. Duncan, T. A. Connors, and H. Meada. Drug targeting in cancer therapy: the magic bullet, what next? J. Drug Targeting 3:317-319 (1996).
2. G. R. Thrush, L. R. Lark, B. C. Clinchy, and E. S. Vitetta. Immunotoxins: an update. Ann. Rev. Immunol. 14:49-71 (1996).
3. F. Gabor, I. Haberl, M. Wirth, K. Richter, G. Theyer, G. Baumgartner, E. Wenzl, and G. Hamilton. In vitro antitumor activity of MIC2 protein-doxorubicin conjugates. Int. J. Onc. 9:527-531 (1996).
4. S. S. Davis and L. Illum. Colloidal carriers and drug targeting. Acta Pharm. Technol. 32:4-9 (1986).
5. J. Kreuter. Nanoparticulate systems in drug delivery and targeting. J. Drug Targeting. 3:171-173 (1995).
6. N. Sharon and H. Lis. Lectins: cell agglutination and sugar specific proteins. Science 177:949-959 (1972).
7. C. M. Lehr in Lectins - Biomedical Perspectives. A. Pusztai and S. Bardocz (eds.) Taylor & Francis Ltd., London 1995.
8. A. Shanghai and S. Hakamori. Molecular changes in carbohydrate antigens associated with cancer. Bioessays 12:223-230 (1990).
9. I. E. Liener, N. Sharon, and I. E. Goldstein, The lectins: properties, functions and applications in biology and medicine, Academic Press, Orlando, Florida, 1986.
10. A. Pusztai, S. W. B. Ewen, G. Grant, D. S. Brown, J. C. Stewart, W. J. Peumans, E. J. M. van Damme, and S. Bardocz. Antinutritive effects of wheat-germ agglutinin and other N-acetylglucosamine-specific lectins. Br. J. Nutr. 70:313-321 (1993).
11. F. Gabor, M. Wirth, G. Walcher, and G. Hamilton. Lectin-mediated bioadhesion: Gastrointestinal stability and binding-characteristics of wheat germ agglutinin and Solanum tuberosum lectin on Caco-2, HT-29 and human colonocytes. J. Contr. Rel. 49:27-37 (1997).
12. H. S. Yang and R. A. Reisfeld. Doxorubicin conjugated with a monoclonal antibody directed to a human melanoma-associated proteoglycan suppresses the growth of established tumor xenografts in nude mice. Proc. Natl. Acad. Sci. USA 85:1189-1193 (1988).
13. M. Wilchek, T. Miron, and J. Kohn. Affinity chromatography. Methods Enzymol. 104:3-55 (1984).
14. R. O. Dillman, D. E. Johnson, D. L. Shawler, and J. A. Koziol. Superiority of an acid-labile daunorubicin-monoclonal antibody immunoconjugate compared to free drug. Cancer Res. 48:6079-6102 (1988).
15. W. C. Shen and H. J.-P. Ryser. Cis-aconityl spacer between daunomycin and macromolecular carriers: a model of pH-sensitive linkage releasing drug from a lysosomotropic conjugate. Biochem. Biophys. Res. Comm. 102:1048-1054 (1981).
16. M. Ramanathan. Flow cytometry applications in pharmacodynamics and drug delivery. Pharm. Res. 14:1106-1114 (1997).
17. K. A. Kronis and J. P. Carver. Specificity of isolectins of wheat germ agglutinin for sialyloligosaccharides: a 360-Mhz proton nuclear magnetic resonance binding study. Biochemistry 21:3050-3057 (1982).
18. Z. Brich, S. Ravel, T. Kissel, J. Fritsch, and A. Schoffmann. Preparation and characterization of a water soluble dextran immunoconjugate of doxorubicin and the monoclonal antibody (ABL364). J. Contr. Rel. 19:245-258 (1992).
19. S. D. Ryder, J. A. Smith, E. G. Rhodes, N. Parker, and J. M. Rhodes. Proliferative responses of HT-29 and Caco-2 human colorectal cancer cells to a panel of lectins. Gastroenterology 106:85-93 (1994).
20. T. Kawamoto, J. D. Sato, A. Le, J. Polikoff, G. H. Sato, and J. Mendelsohn. Growth stimulation of A431 cells by epidermal growth factor: Identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc. Natl. Acad. Sci. USA 80:1337-1341 (1983).
21. F. Y. Zeng, A. Benguría, S. Kafert, S. André, H. J. Gabius, and A. Villalobo. Differential response of the epidermal growth factor receptor tyrosine kinase activity to several plant and mammalian lectins. Mol. Cell Biochem. 142:117-124 (1995).
22. W. Yin and P. W. Cheng. Lectin conjugate-directed gene transfer to airway epithelial cells. Biochem. Biophys. Res. Comm. 205:826-833 (1994).